lung cancer
Conditions
Interventions
Research Group:Comprehensive minimally invasive interventional therapy
Control Group :Concurrent / sequential chemoradiotherapy
Sponsors
Beijing Hospital
Eligibility
Sex/Gender
All
Age
70 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.The patient voluntarily participated and signed the informed consent; 2.The patient's age was over 70 years old (subject to the date of signing the informed consent); 3.The diagnosis of NSCLC was confirmed by pathology (histology or cytology) without EGFR mutation, ALK fusion or ros1 fusion; 4.The patients in the study group were assessed by MDT to be unable to undergo surgery or refused surgery; 5.CT scan showed measurable tumor focus; 6.KPS score >= 60; 7.Results: the function of heart, liver, kidney and lung was normal, and there was no major organ dysfunction; 8.Patients who had not received chemoradiotherapy or minimally invasive interventional therapy within 2 months; 9.The expected survival time is more than 3 months.
Exclusion criteria
Exclusion criteria: 1.Patients with coagulation dysfunction can not be treated with minimally invasive interventional therapy; 2.Previous history of malignant tumor in other parts; 3.Patients with previous severe pulmonary dysfunction, pulmonary ventilation disorder and multiple bullae; 4.Severe infection, uncontrollable diabetes, hypertension and other serious diseases exist; 5.Those who are participating in other clinical trials; 6.There were more than 3 lesions in both lungs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Local efficacy; | — |
Secondary
| Measure | Time frame |
|---|---|
| Progression free survival;Quality of life score;Side effects and complications;Tumor markers; | — |
Countries
China
Contacts
Public ContactLi Xiaoguang
Beijing Hospital
Outcome results
None listed